China Health Industries Holdings, Inc.
Other OTCTotal Valuation
China Health Industries Holdings, Inc. carries a market capitalization of 6,554.00, placing it among publicly traded companies globally. Its enterprise value stands at 31.08M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6,554.00 |
| Enterprise Value | 31.08M |
Share Statistics
China Health Industries Holdings, Inc. currently has 65.54M shares outstanding.
| Shares Outstanding | 65.54M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 266.41, and the price-to-book ratio stands at 0.63.
| PE Ratio | N/A |
| PS Ratio | 266.41 |
| PB Ratio | 0.63 |
| P/TBV Ratio | -7.60 |
| P/FCF Ratio | -0.60 |
| P/OCF Ratio | -0.60 |
Enterprise Valuation
| EV / Sales | 323.93 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
China Health Industries Holdings, Inc. maintains a current ratio of 0.04, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -230.92, indicating conservative leverage, while an interest coverage ratio of -19,498.72 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.04 |
| Quick Ratio | 0.00 |
| Debt / Equity | -230.92 |
| Debt / EBITDA | -5.68 |
| Interest Coverage | -19,498.72 |
Financial Efficiency
| Return on Equity (ROE) | -3.31 |
| Return on Assets (ROA) | -5.18 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.50 |
Stock Price Statistics
China Health Industries Holdings, Inc.'s stock has declined approximately -99.95002% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.04.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.95002% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.04 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, China Health Industries Holdings, Inc. generated 95,946.00 in revenue and converted that into -1.36M in net income, yielding earnings per share of -0.02. EBITDA reached -974,936.00, while operating income came in at -1.38M.
| Revenue | 95,946.00 |
| Gross Profit | -5,118.00 |
| Operating Income | -1.38M |
| Pretax Income | -1.36M |
| Net Income | -1.36M |
| EBITDA | -974,936.00 |
| EBIT | -1.38M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
China Health Industries Holdings, Inc. holds 18,100.00 in cash and equivalents against 5.54M in total debt, resulting in a net debt position of 5.52M. Total book value stands at 40.52M, with working capital of -6.28M providing operational flexibility.
| Cash & Cash Equivalents | 18,100.00 |
| Total Debt | 5.54M |
| Net Debt | 5.52M |
| Equity (Book Value) | 40.52M |
| Book Value Per Share | 0.62 |
| Working Capital | -6.28M |
Cash Flow
China Health Industries Holdings, Inc. produced -42.79M in operating cash flow over the past twelve months.
| Operating Cash Flow | -42.79M |
| Capital Expenditures | N/A |
| Free Cash Flow | -42.79M |
| FCF Per Share | -0.65 |
Margins
China Health Industries Holdings, Inc. operates with a gross margin of -5.33, reflecting its pricing power and cost economics. The operating margin of -1,439.71 and net profit margin of -1,419.55 provide insight into operational efficiency.
| Gross Margin | -5.33 |
| Operating Margin | -1,439.71 |
| Pretax Margin | -1,419.55 |
| Profit Margin | -1,419.55 |
| EBITDA Margin | -1,016.13 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | N/A |
| FCF Yield | -167.42 |
Stock Splits
China Health Industries Holdings, Inc.'s most recent stock split took place on December 3, 2008 with a 20:1 split ratio.
| Last Split Date | 12/3/2008 |
| Split Ratio | 20:1 |
Scores
China Health Industries Holdings, Inc. posts an Altman Z-Score of 16.47, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 16.47 |